Gt Biopharma Inc (GTBP) 13F Positioning & Ownership Changes (Q2 2026)

GTBP ranks #5696 out of 37503 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

60 institutions disclose a position in GTBP, but none treat it as a major bet — even Kitching Partners, LLC, its most concentrated holder, allocates just 0.0% of its own portfolio to it.

Geode Capital Management, LLC has added to its GTBP position for two straight quarters, increasing it by $115.5K to reach $130.6K today.

HBK Sorce Advisory LLC has trimmed its GTBP position for two straight quarters, cutting it by $2.2K while still holding $3.2K.

GTBP reported a net loss of $22.1M over the trailing twelve months.

• Not yet profitable — net loss of $22.1M over the trailing twelve months
• Net income improved year over year, from -$38.1M to -$22.1M
• Operating cash flow was negative, using $12.9M in cash
• Current ratio of 3.50x — enough short-term assets to cover short-term liabilities
• Liabilities run 311.77x equity — a highly leveraged balance sheet worth noting